RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Qiming Venture Partners
Q

Qiming Venture Partners portfolio

Qiming Venture Partners has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. It is a venture capital firm based in Beijing, CN, founded in 2006. It led 2 of the 3 rounds it joined. Its most recent investment on record is Oricell Therapeutics's $70M Series B+ round in January 2026, which it led, alongside Qatari sovereign wealth fund, NGS Super, Lichen Capital and 4 others. By category, its portfolio leans toward Health and bio (1) and Staking and restaking (1). It has co-invested with Qatari sovereign wealth fund, NGS Super and Lichen Capital.

Website: qimingvc.com.
Type: Venture capital.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Rounds led: 2 of 3.
Capital in their rounds: $223M.
Latest deal: Oricell Therapeutics · Jan 13, 2026.

About Qiming Venture Partners

Firm type: Venture capital.
Headquarters: Beijing, CN.
Founded: 2006.
Stages: Seed, Series A, Series B, Growth.
Sectors: AI & Machine Learning, Biotech, Cleantech, Consumer, Digital Health, E-commerce, Enterprise Software, Gaming, Hardware, Healthtech, Medical Devices, Mobility & Transportation, Robotics, Sector Agnostic.
Check size: $5M to $134M.
Leads rounds: No.
Portfolio companies: 426.
Exits: 1.
Rounds led: 0.

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

What Qiming Venture Partners invests in

Qiming Venture Partners recent investments

How Qiming Venture Partners invests

StageDealsCapital in rounds
Series B+ 3 100%$223M
YearDealsCapital in rounds
2022 2 67%$153M
2026 1 33%$70M

Share is of the 3 rounds on Recent Funding that name Qiming Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Qiming Venture Partners portfolio companies

CompanyRound with Qiming Venture PartnersTotal raisedLatest raise
OOricell Therapeutics
Health and bio
Series B+ · $70M · lead$235MApr 10, 2026
round
IInfStones
Staking and restaking
Series B+ · $33M$68MJun 2, 2022
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Qiming Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/qiming-venture-partners (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy